These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 28475642

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection.
    Shang S, Siddiqui S, Bian Y, Zhao J, Wang CR.
    PLoS Pathog; 2016 Jun; 12(6):e1005688. PubMed ID: 27272249
    [Abstract] [Full Text] [Related]

  • 3. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
    Joosten SA, van Meijgaarden KE, van Weeren PC, Kazi F, Geluk A, Savage ND, Drijfhout JW, Flower DR, Hanekom WA, Klein MR, Ottenhoff TH.
    PLoS Pathog; 2010 Feb 26; 6(2):e1000782. PubMed ID: 20195504
    [Abstract] [Full Text] [Related]

  • 4. Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.
    Caccamo N, Pietra G, Sullivan LC, Brooks AG, Prezzemolo T, La Manna MP, Di Liberto D, Joosten SA, van Meijgaarden KE, Di Carlo P, Titone L, Moretta L, Mingari MC, Ottenhoff TH, Dieli F.
    Eur J Immunol; 2015 Apr 26; 45(4):1069-81. PubMed ID: 25631937
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis.
    Chun T, Serbina NV, Nolt D, Wang B, Chiu NM, Flynn JL, Wang CR.
    J Exp Med; 2001 May 21; 193(10):1213-20. PubMed ID: 11369792
    [Abstract] [Full Text] [Related]

  • 7. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
    Rai PK, Chodisetti SB, Maurya SK, Nadeem S, Zeng W, Janmeja AK, Jackson DC, Agrewala JN.
    J Transl Med; 2018 Oct 11; 16(1):279. PubMed ID: 30305097
    [Abstract] [Full Text] [Related]

  • 8. Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis.
    Axelsson-Robertson R, Ju JH, Kim HY, Zumla A, Maeurer M.
    Int J Infect Dis; 2015 Mar 11; 32():13-22. PubMed ID: 25809750
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.
    van Meijgaarden KE, Haks MC, Caccamo N, Dieli F, Ottenhoff TH, Joosten SA.
    PLoS Pathog; 2015 Mar 11; 11(3):e1004671. PubMed ID: 25803478
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.
    Tully G, Kortsik C, Höhn H, Zehbe I, Hitzler WE, Neukirch C, Freitag K, Kayser K, Maeurer MJ.
    J Immunol; 2005 Feb 15; 174(4):2174-84. PubMed ID: 15699149
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis.
    De La Barrera SS, Finiasz M, Frias A, Alemán M, Barrionuevo P, Fink S, Franco MC, Abbate E, del C Sasiain M.
    Clin Exp Immunol; 2003 Jun 15; 132(3):450-61. PubMed ID: 12780692
    [Abstract] [Full Text] [Related]

  • 16. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.
    Lewinsohn DM, Zhu L, Madison VJ, Dillon DC, Fling SP, Reed SG, Grabstein KH, Alderson MR.
    J Immunol; 2001 Jan 01; 166(1):439-46. PubMed ID: 11123322
    [Abstract] [Full Text] [Related]

  • 17. Role of MHC class Ib molecule, H2-M3 in host immunity against tuberculosis.
    Mir SA, Sharma S.
    Vaccine; 2013 Aug 20; 31(37):3818-25. PubMed ID: 23628242
    [Abstract] [Full Text] [Related]

  • 18. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
    Mazzaccaro RJ, Gedde M, Jensen ER, van Santen HM, Ploegh HL, Rock KL, Bloom BR.
    Proc Natl Acad Sci U S A; 1996 Oct 15; 93(21):11786-91. PubMed ID: 8876215
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis.
    Cho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N, Mazzaccaro RJ, Flynn JL, Barnes PF, Southwood S, Celis E, Bloom BR, Modlin RL, Sette A.
    Proc Natl Acad Sci U S A; 2000 Oct 24; 97(22):12210-5. PubMed ID: 11035787
    [Abstract] [Full Text] [Related]

  • 20. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
    Chattopadhyay S, O'Rourke J, Cone RE.
    Int Immunol; 2008 Apr 24; 20(4):509-16. PubMed ID: 18359787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.